Table 3. The relationship between the expression of the survival-associated IRGs and clinicopathological factors in BLCA.

Genes	Age(>65/≤65)			Gender (male/female)			Pathological stage (IV-III/I-II)			T stage (T3-T4/T1- T2)			N stage (N1-3/N0)			M stage (M1/ M0)
	t	P		t	P		t	P		t	P		t	P		t	P
MMP9	-0.078	0.938		0.658	0.513		-1.636	0.105		-1.991	0.048		-0.566	0.573		-1.089	0.322
PDGFRA	0.538	0.591		0.849	0.401		-3.077	0.002		-3.040	0.003		-1.203	0.232		-0.462	0.660
AHNAK	0.760	0.449		1.447	0.157		-3.700	<0.001		-3.933	<0.001		-2.238	0.028		0.942	0.382
OAS1	-2.146	0.034		-2.543	0.013		2.159	0.034		2.148	0.034		1.775	0.079		2.929	0.023
OLR1	-0.763	0.448		0.024	0.981		-1.094	0.277		-1.059	0.292		-0.364	0.717		2.989	0.004
RAC3	0.382	0.703		1.040	0.305		-0.544	0.588		0.066	0.947		-1.703	0.093		-1.129	0.309
IGF1	-0.094	0.925		0.856	0.397		-3.557	<0.001		-3.111	0.002		-1.090	0.279		-0.965	0.373
PGF	0.343	0.732		-0.634	0.529		0.883	0.380		0.270	0.788		2.090	0.039		-0.851	0.431
SH3BP2	-0.798	0.427		0.214	0.832		1.799	0.077		0.900	0.371		2.546	0.012		-0.121	0.908
riskScore	-0.265	0.791		1.693	0.100		-2.981	0.003		-2.754	0.007		-1.381	0.170		-0.412	0.689